tolvaptan has been researched along with Adenocarcinoma, Basal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| B, N; Jayadeep, S; Khan, MF; Pai, K; Varma, M; Vidyasagar, S | 1 |
1 other study(ies) available for tolvaptan and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Syndrome of inappropriate antidiuretic hormone release as the initial presentation of adenocarcinoma of the colon.
Topics: Adenocarcinoma; Colon; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Tolvaptan; Vasopressins | 2020 |